Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06355804 · ClinicalTrials.gov registry record · NA

Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis

A NA study of Multiple Sclerosis, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
52
Enrollment target
1
Study location

NCT06355804 is a NA study of Multiple Sclerosis that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 52 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06355804, a NA study of Multiple Sclerosis, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
52 participants
Enrollment target
1
Study location

Study Summary

The overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a control condition (i.e., waitlist control) in persons newly diagnosed with MS (disease duration ≤ 2 years). Specific Aim 1: To evaluate the changes in self-report and device-measured physical activity after the 16-week remotely delivered physical activity behavior change intervention compared with a control condition (i.e., waitlist control) in persons who have diagnosed with MS within the past two years. The investigators hypothesize that the 16-week behavior change intervention will yield greater improvements in physical activity levels than the control condition immediately after the intervention. Specific Aim 2: To investigate the efficacy of the 16-week, remotely delivered physical activity behavior change intervention compared with the control condition for improvements in fatigue, depression, anxiety, and QoL in persons newly diagnosed with MS. The investigators hypothesize that there will be beneficial effects on the symptoms and QoL outcomes immediately after the physical activity intervention compared with minimal changes in the control condition.

Conditions Studied

Multiple Sclerosis

Interventions

  • BEHAVIORAL Physical activity condition
  • BEHAVIORAL Waitlist condition

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 52 participants
Start Date 2024-04-29
Est. Completion 2026-12-01
Phase NA

Sponsor

University of Illinois at Chicago

430 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06355804

The ClinicalTrials.gov registry entry for NCT06355804 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 52 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (91% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Physical activity condition is the first listed.

NCT06355804 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06355804 about?

NCT06355804 is a clinical study titled "Lifestyle Physical Activity Intervention for Persons Newly Diagnosed With Multiple Sclerosis". The overall objective of the current study is to determine the efficacy of a 16-week remotely delivered lifestyle behavioral intervention compared with a control condition (i.e., waitlist control) in persons newly diagnosed with MS (disease duration ≤ 2 years). Specific Aim 1: To evaluate the chang...

What is the current status of trial NCT06355804?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 52 participants. The study started on 2024-04-29. Estimated completion is 2026-12-01.

What conditions does trial NCT06355804 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT06355804?

The interventions under investigation include: Physical activity condition (BEHAVIORAL), Waitlist condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT06355804?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06355804 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.